I am Dr. Mojtaba Mafi M.D., Medical Doctor/ Physician, graduated from Tehran university, School of Medicine with honor. I studied in neurosurgery ward and graduated with A score with thesis on Meningioma Brain Tumor during 6 years. With continuing my practice with special consideration on psychosomatic disorders, I completed many post graduate courses on health psychology, addiction medicine, sexual disorders therapy successfully. I passed many post graduate courses in Neuro, approved by Medical sciences university. As well, I have been passed post graduate courses on Nutrition, Gastroenterology and hepatology, Obesity treatment and diabetes approved by Tehran University of Medical sciences. I successfully passed more than 10 programs with certificates and membership in Iranian Association of Gastroenterology and Hepatology. Having honor of working as associate of Iran Hepatitis Network and Gastroenterology and Hepatology research center, Middle East Liver Diseases Center (MELD). This strong study background enabled me to successfully earn certificates on 3 programs: Updates of skin and treatment from Tehran university 2015 and course on skin care updates from Iranian society of practitioners on 2016, and during 2 years, I had passed Beauty and Skin care courses in South Korea and certified from Sunghuwan co Ltd for using and working of beauty technology, RF and IPL. I am director of fatty liver and related metabolic disorders study among Iranian families since 2015 and currently publishing the results of our study and research about fatty liver and hyperlipidemia, diabetes and nutrition as study director and clinician associate member of Iran Hepatitis Network. I am reviewer and associate editor of Hepatitis Monthly Journal and reviewer of journal of Clinical and Translational Hepatology. I am editorial board member of International Journal of Psychology and Neurosciences. I am certified graduate, verified reviewer and certified mentor of Publons academy in the field of Clinical Medicine and Hepatology. I am working clinically on patients with Brain Tumor and publishing my results on these topics: 1. Recurrent Meningioma 2. Trigeminal neuralgia 3. Radiation induced meningioma 4. Behavioral change in Brain Tumors 5. DVT prevalence and management among patients with meningioma And some others. I published reviews for articles on Brain Tumor Immunotherapy, CNS Tumor Guideline and Alzheimer disease in Elsevier and Kudos. My review on Alzheimer's disease article with specific DOI, was published in American Physiological Society. I have been invited by editor in chief of American Journal of Translational Medicine, to participate at International Conference of Translational Medicine, in Hawaii. My article entitled "Trigeminal Neuralgia caused by Brain Meningioma" has been accepted for oral presentation in world neurology and Neurodisorders Conference, Tokyo as keynote speaker. My article in the field of neuroscience about 'Recurrent Meningioma', etiologies and clinical aspects and tumor cellular pathology has been accepted for oral, poster presentation in World CNS Conference, France 2018. I am speaker of World Congress on Epilepsy in London. I am speaker of International conference on Central Nervous System and Therapeutics for my accepted article about recurrent Brain meningioma, in Paris 2018. I am speaker of Annual Congress on Neurology and Neuroscience (EuroNeurology 2019) for my accepted article on Brain stroke and meningioma held in paris,2019. My article on trigeminal neuralgia secondary to Brain tumor was accepted for oral presentation in World Brain Congress in Dubai,2018 as Honorable speaker. My article on pulmonary physiotherapy and rehabilitation related to Brain tumor surgery was accepted for oral presentation in 6th World Congress on Physiotherapy and Rehabilitation held in Dubai,2018. One of my works on diabetes and fatty liver as a scientific article has been accepted in 4th International Conference on Diabetes and Its Treatments at Dubai 2018 for oral presentation and publication and another one is about fatty liver and metabolism has been accepted for oral and poster presentation in International Conference of Gastroenterology and Hepatology, Thailand 2018 as Honorable speaker. I am speaker of International Conference on Obesity and Chronic diseases, 2018 in Dubai. My article on fatty liver and vascular disorders was accepted for oral presentation in 6th World Congress on Hypertension and Public Health in France, 2018. I am as well, Organizing Committee Member in International Conference of Obesity and Diet Imbalance in Indonesia, 2018 with accepted article on nutrition and fatty liver for oral presentation. My article on vascular disorders and ischemic heart disease was accepted for oral presentation in Global Congress on Cardiology and Interventional Cardiology held in Dubai, 2019. I am speaker of 7th International Conference on Hypertension and Healthcare in Finland, 2019, for my accepted article on vascular disorders related to fatty liver. I am invited Organizing Committee Member in 3rd International Conference on Alzheimer's Disease and Dementia held in London,2019. As distinguished speaker, my article has been accepted for oral presentation in 22th International Conference on New Horizons in Cardiology and Cardiologist Education held in Berlin, Germany 2019. I am speaker of 12th International Conference on Osteoporosis, Arthritis and Musculoskeletal disorders in London 2019, for my accepted article about discopathy secondary to brucellosis. I am speaker and Organizing Committee Member of 6th International Conference on Rare Disease and Orphan Drug 2019 in Dubai, for my accepted article about rare type of peptic ulcer. My article on psoriasis related to fatty liver was accepted for oral presentation in International Dermatology Conference: Skin and Body, held in Indonesia, 2018 as distinguished speaker. I am Organizing Committee Member of Annual Conference on Neurology and Neuroscience (EuroNeurology 2019) held in France. I am Organizing Committee Member (OCM) of pulsus group conferences in the field of Heart and Cardiology: - OCM of 5th International conference on vascular Biology and Surgeons Meeting London, 2019. - OCM of 2nd Global Heart congress, Osaka, Japan, 2019. - OCM of Global Congress on cardiology and International cardiology, Dubai, 2019. As well, I received organizing committee membership of 15th International conference on Metabolomics and systems Biology Japan. I am organizing committee member of World Congress on cancer science and therapy Rome, Italy. I am organizing committee member of world highest rank conferences in the field of neuroscience: - OCM of Global Experts Meeting on Advances in neurology and neuropsychiatry, Melbourne, 2019. - OCM of European Neurology congress Venice, Italy, 2019. - OCM of International conference on Addictive Disorders and Alcoholism, Brisbane, 2019. - OCM of 5th Global Experts Meeting on Parkinsons, Huntington's and Movement disorders, Japan. With honor I received Organizing Committee membership of 4th World congress on pediatric Neurology and pediatric surgery, Auckland. In the field of Neuroscience, I am Organizing committee member of 4th Annual conference on Brain Disorders, Neurology and Therapeutics, Spain. In scientific federation on Neuroscience, I achieved organizing committee membership of multiple conferences: - OCM of 30th Edition of International conference on Neurology and Neuroscience, Singapore and OCM of Alzheimer's and parkinsons conference, France, 2019. I am distinguished speaker and organizing committee member of 12th International conference on Osteoporosis, Arthritis and Musculoskeletal Disorders, London. As well, I am organizing committee member of International conference on Central nervous System and Neurological Surgeons, London, 2019

Research Interest I am working clinically on patients with Brain Tumor and publishing my results on these topics: 1. Recurrent Meningioma 2. Trigeminal neuralgia 3. Radiation induced meningioma 4. Behavioral change in Brain Tumors 5. DVT prevalence and management among patients with meningioma

Dr. Mohammad Reza Movahed received his MD from Medizinische Hochschule Hannover, Germany. He completed his medical residency at the University of Rochester, New York and his cardiology training at the University of South Caroline, Columbia. His final training in interventional cardiology was completed at Yale University Hospital, New Haven, Connecticut in 2000. After his training, he joined University of California Irvine as Assistant Clinical Professor and later joined University of Arizona College of Medicine in 2006 as Associate Professor of Medicine, Division of Cardiology. In July 2010, Dr. Movahed was promoted to Professor of Medicine, Tenure at the University of Arizona College of Medicine due to his excellent clinical work, teaching, service and research with over 200 peer reviewed publications. He has been Director of Cardiac Catheterization Laboratory and Nuclear Cardiology at the University of California, Irvine medical Center and Director of Coronary Care Unit and Medical Director of Cardiac Transplantation at the University of Arizona Medical Center. In 2007, he joined the Southern Arizona VA Health Care System for his clinical work and as the Medical Director of Heart Transplantation. In May 2012, he joined CareMore as The Regional Cardiology Director of CareMore in Arizona while keeping his teaching and research affiliation with the VA and the University of Arizona as Professor of Medicine, tenure.

His major area of research is related to coronary intervention, non-invasive cardiology and cardiovascular epidemiology. He is world-renowned for his coronary bifurcation classification known as “The Movahed Classification” He is also known for his discovery on the flattening of interventricular septum as a sign for right ventricular overload the so called “ Movahed’s sign” that can be seen during Gated SPECT studied and recently published reverse “Movahed Maneuver” that can be used for improvement of stent deliverability during difficult and tortuous vein graft interventions.

iamond possess 15 + years of experience in the healthcare industry. He has been featured extensively in the media as your trusted authority on heart disease rehabilitation and prevention and is also dynamic speaker educating his audiences on various topics on heart health and chronic disease management. Diamond Fernandes is a clinical physiologist focusing on Cardiac Rehabilitation, Maintenance and Heart Attack and Stroke Prevention. Look out for his new book called "Beating Heart Disease". He has brought External ounterpulsation Therapy, also known as EECP and ECP to his cardiac rehabilitation patients and has seen amazing outcomes to prevent and reverse heart disease. Diamond, also focuses on Corporate Heart Health wellness programs to eliminate heart & chronic disease in the workplace. Delivers presentation to other healthcare professionals. As the director, of a private cardiac wellness program, he is responsible for business development through marketing and sales. He has established clinic systems which include operational, networking, corporate vision, and execution. He has an extensive background in business training, franchising/licensing (healthcare) and internet marketing promoting heart health.

Cardiac rehabilitation programming; External Counterpulsation Therapy, ECP, EECP; CVD treatment; Chronic disease management; Heart disease treatment; heart attack rehabilitation; corporate wellness programs; cardiac rehabilitation; hypertension; cholesterol; diabetes; overweight; family history; physical inactivity; strokes; blood clots; DVT; arrhythmia; heart failure; cardiomyopathy; atrial fibrillation

amien Byas is the President, North American Scientific Committee on Cardiovascular Health, USA as well as an Epidemiologist and Professor of Public Health, American Public Health Association, International Public Health Delegate, USA.

Cardiology, Cardiovascular Diseases, Epidemiology

Dr. Beder was graduated from La Plata University, School of Medicine, and I was completed Cardiology training at Hospital Interzonal General de Agudos San Juan de Dios, La Plata, Argentina. I'm staff of Cerhu Clinic and Chief of Cardiology of Italia Clinic in San Luis, Argentina, and I completed training in echocardiography and nuclear medicine. I was involved in many educational programs as a Teacher and Director. Some of those programs for echocardiographers in training. I'm Professor in Physiology, Physiopathology and Internal Medicine at Facultad de Medicina, Universidad Católica de Cuyo, San Luis, Argentine. I'm cardiologist at Argentinian Federation of Cardiology and Argentinian Society of CArdiology. I've published original researches in local journals. I've been invited as a guest lecturer in the most Scientific Sessions of the Argentinian Federation of Cardiology since 1996. I was president of San Luis Society of Cardiology in 2007. I was a President from National Congress of Cardiology in 2014

Cardiology, Cardiovascular Diseases

Aris Lacis, cardiac surgeon, professor, MD, PhD graduated Riga Medical Institute in 1961. General and thoracic surgeon in P. Stradina University Hospital in Riga (1964–1969). Thoracic and cardiac surgeon in the Latvian Centre for Cardiovascular Surgery (1969–1994). Since 1994 until 2012 – the head of Pediatric Cardiology and Cardiac Surgery Clinic in University Children’s Hospital, Riga; since 2012 – a consulting professor of this Clinic. Vicepresident of Latvian Society for Cardiovascular Surgery. President of Latvian Association for Pediatric Cardiologists. Author of 395 scientific publications, 3 monographs and 13 patents. Investigator in more than 10 clinical trials including cardiosurgical procedures performed under deep hypothermia, hybrid procedures etc. In May 2009 have been used transcutan intramyocardial delivery techniques for treatment (idiopathic dilated cardiomyopathia) the first 3 months aged patient in the world with autologous bone marrow derived progenitor cells. In November 2010 the first patient with end stage pulmonary hypertension received intrapulmonary implantation autologous stem cells.

Pediatric Cardiology, Cardiovascular Surgery

Michiaki Nagai has completed his graduation from the Jichi Medical University School of Medicine and has been engaged in the Cardiovascular Medicine. Using volumetric analysis in MR SPGR imaging, he has been investigating the fields for target hypertensive organ damages including the relationships among hypertension, blood pressure variability, brain atrophy, cognitive impairment and central autonomic nervous system including the insular cortex. He was engaged in the Interventional Cardiology at Hiroshima City Asa Hospital as the Vice Director. He won the Japanese Society of Hypertension Award in the International Society of Hypertension 2006, the Young Investigator’s Award in the 8th Japanese Neurocardiology Workshop 2007 and Young Scientist Award in the second annual scientific forum of clinical hypertension of the Japanese Society of Hypertension 2013.

Hypertension, Interventional Cardiology, Cardiovascular Medicine

Carola Förster has a convincing track record in (neuro)physiology with a strong focus on the (dis)functions of the blood-brain barrier (BBB). A significant aspect of her research is related to regulation of gene expression at the BBB, specifically by non-coding RNA, particular microRNA, to offer pharmacological solutions to the observed BBB alterations. For this, CF systematically studies the mechanisms from gene regulation, through transcription, to protein degradation and cellular morphology, linking basic science with clinical aspects. After years of experience in research, evaluation, teaching and administration both in hospital and education institutions, CF developed different in vitro and in vivo models of cerebrovascular disease and established recently a division of computational model to further strengthen this area of research.

heart failure and stroke, neurophysiology

Mary Shibuya is an experienced native English medical editor/writer of 32 years living in Japan with a background in chemistry and allergy research at Mayo Clinic (Rochester, MN). For 23 years she was the language editor of the journal Internal Medicine, published by the Japanese Society of Internal Medicine. In addition to editing and preparing research articles for publication in international journals, she attended various medical/scientific congresses as Press (interviews, transcription, summarizing). She also enjoys lecturing on scientific medical writing in English to graduate schools and pharmaceutical companies. She strives to encourage ESL doctors/researchers to publish in English.

allergy research,chemistry,scientific medical writing

Dr. Hallak is currently Chief of Interventional Cardiology Department at American Hospital Dubai, President (gulf Chapter) of international Society of Endovascular Specialists, Chairman of 4TS international conference, and previous Board Member of Emirate Cardiac Society. Dr. Hallak received his post graduate training and research in United States at University of Illinois, Chicago, North Western University and Louisiana University in New Orleans. He is Board Certified in Interventional Cardiology, Cardiovascular Disease, Vascular Medicine, Endovascular Medicine, Nuclear Cardiology and Internal Medicine. He was the Head of Cardiology Department at Saint Francis Hospital in USA, and assistant Professor at LSU New Orleans and University of West Virginia. He has performed thousands of procedures including Cardiac and Peripheral Vascular Intervention in addition to Pacemaker and ICD/ CRT Implantation. He participated in many national and international research studies with many publications. He involved extensively in local, regional and international cardiology conferences as a Speaker and as a Chairman.

Interventional Cardiology, Cardiovascular Disease, Vascular Medicine, Endovascular Medicine, Nuclear Cardiology and Internal Medicine

Dr. Ellahham has served as Chief Quality Officer for SKMC since 2009. In his role, Dr. Ellahham has led the development of a quality and safety program that has been highly successful and visible and has been recognized internationally by a number of awards. As Chief Quality Officer and Global Leader, Dr. Ellahham has a focus on ensuring that that implementation of this best practices leads to breakthrough improvements in clinical quality and patient safety.

Cardiovascular Research

Galya Naydenova Atanasova completed her Ph.D. training in Cardiology from Department of Cardiology, Pulmonology and Endocrinology at Pleven Medical University, Bulgaria. She is a Cardiologist, Assistant Professor at the Department of Internal Medicine, Medical University, Pleven. She is a General Practitioner in Pleven. She specialized in Cardiology from Pleven Medical University during 2015, and General Medicine from Pleven Medical University, Bulgaria during 1993. She has attended to many International Events and presented her research work. She did many researches on metabolic syndrome and myocardial infarction of heart.

metabolic syndrome and myocardial infarction of heart

Dr. Satoru Takeno graduated from Akita University in 2001. After completing the residency program at the International Medical Center of Japan, he started his career as a pediatric cardiologist at Kyoto University Hospital. Since 2011, he has been engaged in pediatric electrophysiology and catheter ablation at Kindai University.

Pediatrics, Pediatric Electrophysiology

Dr. Hany Eteiba MD FRCP(Glas.) FRCP(Edin.) FACC FSCAI FIACS Associate, Consultant Cardiologist, Regional and National Medicine-Director, Associate Medical Director, West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Glasgow Royal Infirmary. He is the Medical Director - Regional and National Medicine Consultant Interventional Cardiologist, West of Scotland Heart & lung centre, Golden Jubilee National Hospital Glasgow Royal Infirmary Honorary Clinical Senior Lecturer, Glasgow University Fellow of the Royal College of Physicians and Surgeons of Glasgow. Dr Eteiba is also a member of the Royal College of Physicians of Edinburgh, member of the American College of Cardiology, member of the American Society for Cardiovascular Angiography and Interventions, Elected Council member of RCPSG and Medical Advisor of the International committee of Glasgow Royal College of Physicians and Surgeons.

Interventional Cardiology, Heart disease, Heart failure

Guy H Fontaine has made 17 original contributions in the design and the use of the first cardiac pace makers in the early 60s. He has serendipitously identified ARVD during his contributions to antiarrhythmic surgery in the early 70s. He has developed the technique of Fulguration to replace surgery in the early 80s (technique used during 30 years in Paris). He has been one of the 216 individuals who have made a significant contribution to the study of cardiovascular disease since the 14th century, one of the 500 greatest geniuses of the 21th Century (USA Books), one of the 100 Life Time Achievement (UK Book). He has more than 900 publications including 201 chapters in books.. He is the reviewer of 26 scientific journals both in basic and clinical science. He served as a member of the Editorial Board of Circulation for 5 years, after reviewing articles for this journal during decades. He has given 11 master lectures of 90 minutes each in inland China in 2014. He has recently developed new techniques of hypothermia for brain protection in OHCA and Stroke. This technique has been fortuitously used after resuscitation of his wife at home in June 2011 with absolutely no neurologic deficit despite 6 minutes of no flow. He has also invented a high-tech device which can be considered the ultimate in palliative care by preventing unexpectedly awaking after ordinary sleep. This device was mostly designed for major neurologic disorders.

cardiovascular diseases, Antiarrhythmic Surgery, Stroke, Neurologic disorders

Dayi Hu is the President of the Chinese Society of Cardiology (CSC), President of the China Committee of Cardio-Cerebral-Vascular Diseases of GSC, a past president of the Chinese College of Cardiovascular Physicians (CCCP), Chief of the Intervention Centre at Peking University People’s Hospital, Dean of Clinical Research Institute at Shanghai’s Fudan University and a member of The International Academy of Sciences for Europe and Asia(IASEA). Professor Dayi Hu is a member of the Board of Directors of the International Society of Cardiovascular Pharmacotheraphy (ISCP), the editor-in-chief of Chinese Journal of Cardiology, an international board member of Journal of Clinical Cardiology, Journal of the American College of Cardiology, European Heart Journal, Nature Cardiovascular Medicine and also many other national and international medical journals. Professor Hu has been the editor-in-chief or major translator of 50 professional books, three of which have been published in United States.

Cardiology, Cardiovascular Pharmacology, Cardio-Cerebral-Vascular Diseases

He graduated from Osaka university Medical School in 1966 and joined a research group of Lipid Research Laboratory at Osaka University in 1969. He became Professor of the second Department of Internal Medicine of Osaka University in 1991 until 2003 when he moved to Sumitomo Hospital as Director and Emeritus Professor of Osaka University. He has long worked on hyperlipidemia and obesity. He has discovered several novel disease entities such as "Autoimmune hyperchylomicrolemia" and "HyperHDLcholesterolemia caused by CETP deficiency"　He was also interested in body fat distribution with respect to morbidity. He developed the method for fat analysis using CT scan and established the concept named visceral fat syndrome in which cardiovascular risks cluster by visceral fat accumulation. He also investigated biological characteristics of adipose tissue and found that adipose tissue abundantly expressed bioactive substances. (Gene 190:227, 1997, Nature Med 2: 800, 1996) During these works, he discovered "adiponectin" which may be one of key players in the mechanism of obesity-related diseases. He is currently President of International Atherosclerosis Society.

Atherosclerosis, Obesity-related diseases , Cardiovascular Diseases

Dr. Santoso Karo Karo MPH, SpJP (K) FIHA ,FAsCC was born on October 1,1945 at present he is the Chairperson of PERKI Foundation, Consultant Cardiologist, Parliament Health Service, Teaching Staff, Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia. He is the part of many organizations as Member,Indonesian Medical Association, Past President, Indonesian Heart Association (PERKI), Chairperson, Board of Ethics, Indonesian Heart Association (PERKI), Co-founders, Indonesian Society of Hypertension (InaSH), Co-founders,Asia Pacific Society of Hypertension (APSH)

Clinical Cardiology, Cardiovascular Medicine, Hypertension

Haruki Okamura Hyogo College of Medicine Japan

Cardiology, Tumor Immunology and Cell Therapy

Dr Antonia Anna Lukito is Interventional consultant cardiologist at Siloam Karawaci Hospital and currently Head of Cardiovascular Department in Pelita Harapan University, and also an Independent Consultant of MRIN Ethics Committee. Dr Antonia joining several overseas formal courses such as Advanced Cardiology Course at Victoria Heart Center Melbourne in 1996, Cardiovascular CT Training at Cologne Germany in 2005, Carotid Intervention Training at NTUH Taipei 2012, Optical Coherence Tomography(OCT) Training at Finlandia 2012, and Rotablator & IVUS hands-on training at Japan in 2013. She also actively involved in Indonesian Heart Association (PERKI) as vice chairman of Indonesian Heart Consumer Cooperatives (KKJI), chairman of Woman Cardiology working roup, and as scientific & education committee in IHA Banten chapter. Dr Antonia also active in Indonesian Society of Hypertension (InaSH), Indonesian Heart Rhythm Society (InaHRS), and Indonesian Society of Interventional Cardiology (ISIC).

Interventional Cardiology ,Hypertension, Cardiovascular Research

1. Mary Shibuya is an experienced native English medical editor/writer of 32 years living in Japan with a background in chemistry and allergy research at Mayo Clinic (Rochester, MN). For 23 years she was the language editor of the journal Internal Medicine, published by the Japanese Society of Internal Medicine. In addition to editing and preparing research articles for publication in international journals, she attended various medical/scientific congresses as Press (interviews, transcription, summarizing). She also enjoys lecturing on scientific medical writing in English to graduate schools and pharmaceutical companies. She strives to encourage ESL doctors/researchers to publish in English.

allergy research,chemistry,scientific medical writing

Bambang Budiono has his expertise in interventional cardiology for 15 years. He has a lot of clinical experience and involved in some international registration and trials. His interest and expertise in interventional cardiology is well known, which make him invited as faculty in a lot of regional and international meetings.

Interventional cardiology, Heart Diagnosis

Dr. Robaayah Zambahari is known for her extensive experience in cardiology, both locally and internationally. Dr Robaayah is CEO and managing director of the National Heart Institute (IJN) in 2009. She pursued medicine at University of Malaya in 1977 and received speciality training at the Academy of Medicine of Malaysia. She was appointed senior consultant cardiologist and head of department at IJN in 1992. She is a member of Royal College of Physicians of Glasgow, the Royal College of Physicians of London, and the American College of Cardiology, Emeritus member of the Asia Pacific Society of Interventional Cardiology , FAPSIC, October 2006, Member of the National Heart Association of Malaysia, Member of the ASEAN Federation of Cardiology.

Clinical research in cardiology,Interventional Cardiology,Development of Evidence-based Clinical Practice Guidelines

Prof. Rui M. S. Almeida is Portuguese, born in Inhambane, Mozambique, and started medical school in Lisbon (Portugal). Received medical degree from the Parana Federal University - Brazil, in 1980. Rui Manuel de Sousa Sequeira Antunes de Almeida is the board member of the Paraná’ Society of Cardiovascular Surgery, since 2002, and became its President (2006-08). Was elected President of the South Brazilian’ Society of Cardiovascular Surgery (2007-09), a Member of the Board of the Brazilian’ Society of Cardiovascular Surgery (2009-2010), President of the Board (2011-2013) and President of the Endovascular Department of the Brazilian’ Society of Cardiovascular Surgery (2011-2013), Scientific Director of the Brazilian’ Society of Cardiovascular Surgery (2014-15) and Vice-President for the period of 2016-17. As an active member of the Brazilian Society of Cardiovascular Surgery, has represented it in meetings with the Medical Brazilian Association, the European Association of Cardiothoracic Surgery, the World Society of Cardio-Thoracic Surgeons, in which is the delegate for Brazil, and other international and national medical societies. He has published more than 100 papers in peer reviewed national and international, medical journals and presented more than 250 papers in scientific meetings. Was invited to lecture at specialized meetings more than 100 times, in Brazil, Argentina, Canada, China, Croatia, France, Greece, Italy, Portugal, Slovenia, Spain, Sweden, United Kingdom and United States of America. He is also part of the editorial board of ten international journals and five Brazilian.

Cardiovascular Surgery ,Cardiothoracic Surgery

Dr. Beder was graduated from La Plata University, School of Medicine, and I was completed Cardiology training at Hospital Interzonal General de Agudos San Juan de Dios, La Plata, Argentina. I'm staff of Cerhu Clinic and Chief of Cardiology of Italia Clinic in San Luis, Argentina, and I completed training in echocardiography and nuclear medicine. I was involved in many educational programs as a Teacher and Director. Some of those programs for echocardiographers in training. I'm Professor in Physiology, Physiopathology and Internal Medicine at Facultad de Medicina, Universidad Católica de Cuyo, San Luis, Argentine. I'm cardiologist at Argentinian Federation of Cardiology and Argentinian Society of CArdiology. I've published original researches in local journals. I've been invited as a guest lecturer in the most Scientific Sessions of the Argentinian Federation of Cardiology since 1996. I was president of San Luis Society of Cardiology in 2007. I was a President from National Congress of Cardiology in 2014

Cardiology, Cardiovascular Diseases

Consultant cardiologist and Bahrain’s first interventional cardiac electrophysiologist. He is the head of electrophysiology department; cardiac pacing and tachyarrhyhmia devices in Mohammed bin Khalifa bin Salman Al Khalifa Cardiac Centre at Bahrain Defence Force Hospital. He is board certified in internal medicine and adult cardiology from University of Toronto, Canada. Subsequently he did a sub-speciality clinical fellowship in cardiac electrophysiology at Toronto General Hospital. During his cardiology residency and clinical fellowship years he did a research focusing on the “Spatial organization of ventricular fibrillation in explanted Langendorff human heart” which he presented in the annual Ursula Bangs Clinical and Research day at University of Toronto. Subsequently he presented his research at the Canadian Cardiovascular Society Meeting in Montreal/Canada and then submitted an abstract at the American Heart Association. After returning from Canada he established the country's first electrophysiology (EP) laboratory in 2010, subsequently established an advanced EP program utilizing 3D mapping system and established a program for cryoablation of atrial fibrillation. He was the past president of the Gulf Heart Rhythm Society (GHRS). He is a fellow of the Gulf Heart Rhythm Society, Fellow of The Royal College of Physicians of Canada and a Fellow of the Westminster College in Vancouver. He is an Arab Board Examiner for adult cardiology. He received the following honors and decorations; Hawar Medal of a first grade, Military Assessment Medal 1st Class and Medal of Courage. His research interests include atrial fibrillation, new oral anticoagulants, cardiac devices and sudden cardiac death.

atrial fibrillation, new oral anticoagulants, cardiac devices and sudden cardiac death

Roberto Colque to date is Chief of Intensive Care Unit at Sanatorio Allende Cerro in Cordoba City, Staff of Cardiology Service at Sanatorio Allende Cerro. Past President of Cardiology Society of Cordoba. Member of Heart Failure Committee of Argentine Federation of Cardiology. Abstract reviewer of World Heart Failure Congress held in 2015 and 2016. Speakers of topics in National Heart Congress from 2010-2016 about topics of Heart Failure, Acute Heart Failure, and Coronary Syndromes. Pre grade studies made in National University of cordoba at December 1987. Residence in Cardiology at Hospital Itlaiano de Cordoba until 1991. coordinator of Coronary Unit from 1992-1994. Chief Of Coronary Unit at Italian Hospital since 1994 until 2006. Head of Cardiology Service at Clinica Velez Sarsfield 2006-2013. Post graduate activity in Hospital 12 de Octubre Madrid at Heart Failure and Transplation Unit (1993) Visitor at Buenos Aires Italian Hospital 1994 specializing on Postoperative recovery unit. Visitor at Cleveland Clinic in 1995.

Heart Failure, Heart Transplantation, Cardiology